A Comprehensive Approach To Nocturnal Hypoglycemia Monitoring
Main Article Content
Abstract
Night time hypoglycaemia can be a concern for diabetic patients. It occurs when blood sugar levels drop too low during the night, potentially leading to symptoms such as sweating, confusion, irritability, or even loss of consciousness. It's crucial for diabetic patients and their caregivers to be aware of the signs and symptoms of hypoglycaemia and to take preventive measures, as individuals with type I diabetes often face increased challenges with this condition. The aim of uninterrupted glucose monitoring in correlation with heart rate and for diabetic patients who are at risk of night time hypoglycaemia, having a caregiver or a nocturnal monitoring system in place can be crucial for their safety and well-being. Nocturnal hypoglycaemia monitoring involves continuous or periodic checking of blood sugar levels throughout the night to detect and address any drops in glucose levels promptly. For daytime care of diabetic patients, advanced technology plays a crucial role in monitoring and managing their condition effectively. This monitoring can be done manually by a caregiver who wakes up periodically to check the patient's blood sugar levels with a glucose meter. Alternatively, Continuous Glucose Monitoring (CGM) systems can provide real-time glucose readings throughout the night, alerting both the patient and caregiver to any concerning fluctuations. Temperature during the nocturnal period is to improve the detection and management of hypoglycaemia, thereby enhancing overall health outcomes and quality of life for individuals with diabetes. This project provides real-time data on blood glucose levels, which is particularly important for individuals with diabetes. This plays a crucial role during the night when individuals may not be awake to sense symptoms. Monitoring temperature alongside glucose levels and heart rate can provide a more comprehensive understanding of the body's response to hypoglycaemia and may offer additional insights into its detection and management of hypoglycaemia, which can be dangerous and lead to complications if not addressed promptly. It allows for the continuous tracking of glucose levels, enabling the early detection of hypoglycaemic events and the adjustment of therapy to prevent them. Additionally, CGM can be used to analyse the correlation between physical activity and hypoglycaemia, as well as to make well-founded decisions on glucose intake for hypoglycaemia
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360:129–139.
Perreault L, Rodbard H, Valentine V, Johnson E. Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes. Adv Ther. 2019; 36:265–277.
Thrasher J. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies. Am J Med. 2017; 130: S4–S17.
Bae JP, Duan R, Fu H, Hoogwerf BJ. Risk factors for nocturnal hypoglycemia in insulin-treated patients with type 2 diabetes: a secondary analysis of observational data derived from an integrated clinical trial database. Clinical Therapeutics. 2017; 39(9):1790–8. e7.
Pazos-Couselo M, García-López JM, González-Rodríguez M, Gude F, Mayán-Santos JM, Rodríguez-Segade S, et al. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study. Can J Diabetes. 2015; 39:428–33.
Blumer I, Clement M. Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges. Clin Ther. 2017; 39: S1–S11.
Sudharsan B, Peeples M, Shomali M. Hypoglycemia prediction using machine learning models for patients with type 2 diabetes. J Diabetes Sci Technol. 2015; 9(1):86-90.
Vu, L.; Kefayati, S.; Idé, T.; Pavuluri, V.; Jackson, G.; Latts, L.; Zhong, Y.; Agrawal, P.; Chang, Y.C. Predicting nocturnal hypoglycemia from continuous glucose monitoring data with extended prediction horizon. In Proceedings of the AMIA Annual Symposium Proceedings, Washington, DC, USA, 16–20 November 2019; Volume 2019, pp. 874–882.
Zick R, Petersen B, Richter M, Haug C, SAFIR Study Group. Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with type 2 diabetes on multiple daily insulin injection therapy. Diabetes Technol Ther. 2007; 9:483–92.
Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylurea. Arch Intern Med. 1997; 157:1681–6.